
Medical Intelligence Quiz
Challenge Yourself, Build Your Knowledge
The role of TGF-beta in human cancer
Question 1 of 5
Topics
Head & Neck Cancers
Head & Neck Cancers
Quiz | |
---|---|
Risk and prevalence of oropharyngeal cancers | Take Quiz |
Oropharyngeal squamous cell carcinoma | Take Quiz |
ATA Guidelines: Histopathologic evaluation of thyroidectomy samples in patients with DTC | Take Quiz |
ATA Guidelines: Secretory products & morphological examination of MTC | Take Quiz |
ATA Guidelines: Intraoperative voice and parathyroid management & follow-up in patients with DTC | Take Quiz |
ATA Guidelines: Voice and parathyroid issues in DTC | Take Quiz |
ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
ATA Guidelines: Management of medullary thyroid | Take Quiz |
Thyroid cancer trends in the United States | Take Quiz |
DTC detection in obese and non-obese patients | Take Quiz |
Staging: Papillary & follicular thyroid cancer | Take Quiz |
Prognostic & risk factors of thyroid cancer | Take Quiz |
Thyroid nodules & thyroid metastases | Take Quiz |
Postoperative treatment of WDTC | Take Quiz |
Recurrent thyroid cancer | Take Quiz |
Thyroid gland malignancies: DTC, MTC, & ATC | Take Quiz |
Surgical treatment: Stage III & IV papillary & follicular thyroid cancer | Take Quiz |
The breast-thyroid cancer link | Take Quiz |
ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
Impact of low iodine diet in DTC | Take Quiz |
ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
Epidemiology & clinical presentation of parathyroid carcinoma | Take Quiz |
Diagnosis & treatment of parathyroid carcinoma | Take Quiz |
Diagnosis & treatment of medullary thyroid cancer | Take Quiz |
Thyroid cancer outcomes | Take Quiz |
Clinical presentation & diagnosis of thyroid cancer | Take Quiz |
ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
Surgical treatment of primary stage differentiated thyroid cancer | Take Quiz |
Treatment of differentiated thyroid cancer | Take Quiz |
Types of differentiated thyroid cancer | Take Quiz |
CNS/Brain Cancer
CNS/Brain Cancer
Quiz | |
---|---|
Types of gliomas | Take Quiz |
Therapy for glioblastoma | Take Quiz |
Glioblastoma: Reducing complications | Take Quiz |
Glioblastoma & radiation therapy | Take Quiz |
CNS malignancies: Laboratory studies, imaging, & molecular markers | Take Quiz |
CNS malignancies: Management of complications | Take Quiz |
Diffuse glioma: Risk factors | Take Quiz |
In the News: Glioblastoma | Take Quiz |
CNS malignancies: Epidemiology & pathophysiology | Take Quiz |
CNS malignancies: Classification | Take Quiz |
Genitourinary Cancer
Genitourinary Cancer
Quiz | |
---|---|
Prostate cancer in the US | Take Quiz |
Prevalence of bladder cancer | Take Quiz |
Non-muscle invasive bladder cancer | Take Quiz |
Muscle invasive bladder cancer | Take Quiz |
ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
RCC subtypes: Risk factors, clinical findings, & imaging | Take Quiz |
AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
Common RCC subtypes | Take Quiz |
AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
Testicular cancer: Staging & risk stratification | Take Quiz |
AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
AHRQ Review: Management of renal masses & localized renal cancer | Take Quiz |
Staging & surveillance of RCC | Take Quiz |
Understanding urethral cancer | Take Quiz |
Management of penile cancer | Take Quiz |
Minimally invasive surgery for RCC | Take Quiz |
Pathophysiology & prognosis of RCC | Take Quiz |
Risk factors & clinical features of bladder cancer | Take Quiz |
Histopathology of bladder cancer | Take Quiz |
Unique patient categories in RCC | Take Quiz |
Management of localized RCC | Take Quiz |
Serum tumor markers & testicular cancer | Take Quiz |
Epidemiology & risk factors associated with testicular cancer | Take Quiz |
AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
Clinical features and pathology of bladder cancer | Take Quiz |
Treatment options for stage I & II RCC | Take Quiz |
Treatment options for RCC | Take Quiz |
RCC tumor characterization: Laboratory & imaging studies | Take Quiz |
Genetic risk factors associated with RCC | Take Quiz |
RCC subtypes | Take Quiz |
Pathology & natural history of renal cancer | Take Quiz |
RCC: Links & risk factors | Take Quiz |
Clinical features & management of RCC | Take Quiz |
Epidemiology & etiology of RCC | Take Quiz |
Risk factors and pathology of prostate cancer | Take Quiz |
Prostate cancer: Disease detection | Take Quiz |
Diagnosis & prognosis of bladder cancer | Take Quiz |
Classification of renal cell cancer | Take Quiz |
Staging of testicular cancer | Take Quiz |
Risk factors & prostate cancer | Take Quiz |
ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
Survival in advanced prostate cancer | Take Quiz |
Understanding bladder cancer | Take Quiz |
Treatment of prostate cancer | Take Quiz |
Immunotherapy
Immunotherapy
Quiz | |
---|---|
Immune checkpoints & non-specific immunotherapies | Take Quiz |
Monoclonal antibodies, adoptive cell therapy, & cytokines | Take Quiz |
Targeting inhibitors of immune responses & nonspecific immunotherapy | Take Quiz |
Active specific immunotherapy | Take Quiz |
Therapeutic antibodies, vaccines & immune system modulators | Take Quiz |
Passive cellular cancer immunotherapy | Take Quiz |
Adoptive cell transfer & immune checkpoint modulators | Take Quiz |
Types of immunotherapy | Take Quiz |
Cancer preventive & cancer treatment vaccines | Take Quiz |
Gene-expression profiling of tumors for immunotherapy | Take Quiz |
Non-specific cancer immunotherapies & adjuvants | Take Quiz |
Cancer cells & the immune system | Take Quiz |
Cancer treatment: Monoclonal antibodies | Take Quiz |
Forms of immunotherapy | Take Quiz |
Breast cancer: Emerging immunotherapy options | Take Quiz |
Immunotherapy & non-small cell lung cancer | Take Quiz |
Immune checkpoints & their inhibitors | Take Quiz |
Immune checkpoint inhibitors & tumors with mismatch repair deficiency | Take Quiz |
PD-based cancer immunotherapy | Take Quiz |
The role of TGF-beta in human cancer | Take Quiz |
Immune checkpoint blockade: Tumor interferon signaling | Take Quiz |
Efficacy of adoptive T-cell therapy | Take Quiz |
Targeting the necrosome for cancer therapy | Take Quiz |
Mechanisms involved in the tumor microenvironment | Take Quiz |
B-cell receptor CD4+ T cells in cancer immunotherapy | Take Quiz |
Improving T-cell potency via the CAR spacer | Take Quiz |
ROR gamma agonists & antitumor immunity | Take Quiz |
Role of B cell regulation in carcinogenesis | Take Quiz |
Cancer therapies: Vaccine adjuvants, Part 2 | Take Quiz |
Cancer therapies: Vaccine adjuvants, Part 1 | Take Quiz |
Validation of biomarkers to predict cancer immunotherapy response | Take Quiz |
Immune checkpoint modulators & immune cell therapy | Take Quiz |
Function of Hippo pathway kinases in cancer | Take Quiz |
Cancer immunotherapy: Immune checkpoint blockers | Take Quiz |
Cancer immunotherapy target: Wnt/β-catenin signaling in dendritic cells | Take Quiz |
Understanding oncolytic viruses | Take Quiz |
Cancer immunotherapy: Producer T cells – Part 2 | Take Quiz |
Cancer immunotherapy: Producer T cells – Part 1 | Take Quiz |
Cancer immunotherapy: Oncolytic viruses | Take Quiz |
Immune checkpoint blockade in cancer therapy | Take Quiz |
Cancer immunotherapy: Targeting microRNAs | Take Quiz |
Cancer immunotherapy: Role of Tcon & Treg | Take Quiz |
IL-24 in immunotherapy | Take Quiz |
Key omics modalities for precision oncology | Take Quiz |
CAR T cell therapy in cancer treatment | Take Quiz |
Categories of tumor antigens | Take Quiz |
Checkpoint blockade therapy: Immune monitoring assays | Take Quiz |
Cancer immunotherapy: TCR design | Take Quiz |
Novel approaches to cancer immunotherapy | Take Quiz |
Principles of cancer immunotherapy | Take Quiz |
PD-1/PD-L1 immune checkpoint blockade therapy | Take Quiz |
Approaches to cancer immunotherapy | Take Quiz |
Oncolytic viruses as immunotherapy | Take Quiz |
Cancer immunotherapy mechanisms, advantages, & disadvantages | Take Quiz |
Immunotherapy in MIS CRC | Take Quiz |
Cancer immunotherapy: CAR design | Take Quiz |
Precision immunotherapy | Take Quiz |
Molecular mechanisms of immune avoidance | Take Quiz |
Immunotherapy for brain tumors | Take Quiz |
Adenosine in the tumor microenvironment | Take Quiz |
The role of TILs and MILs in cancer therapy | Take Quiz |
Leveraging the antigenic identity of tumors | Take Quiz |
Advances in cancer immunotherapy | Take Quiz |
Novel technologies for cancer immunotherapy | Take Quiz |
Understanding cancer immunology & immunotherapy | Take Quiz |
Personalized cancer immunotherapy: Novel immune monitoring | Take Quiz |
Understanding cancer immunotherapy | Take Quiz |
Patient & Survivor Care
Patient & Survivor Care
Quiz | |
---|---|
Cachexia in cancer | Take Quiz |
HCT & non-HCT cancer survivors: Morbidity & mortality | Take Quiz |
ASCO Guidelines: Integrating palliative care | Take Quiz |
Fertility preservation among cancer patients | Take Quiz |
Gastroenterology
Gastroenterology
Quiz | |
---|---|
Treatment for GI carcinoid tumors | Take Quiz |
Treatment approaches for pancreatic cancer | Take Quiz |
Pancreatic cancer prognosis & overall survival | Take Quiz |
Diagnostics for GI carcinoids: Biochemical markers & imaging | Take Quiz |
Cellular classification of pancreatic cancer | Take Quiz |
Duodenal carcinoids: Clinical features | Take Quiz |
Appendiceal & colorectal carcinoids | Take Quiz |
Pancreatic cancer: Clinical features & diagnosis | Take Quiz |
Jejunal and ileal carcinoids | Take Quiz |
GI carcinoid tumors: Genetics & carcinoid syndrome | Take Quiz |
PDA complications & heritable risk factors | Take Quiz |
GI carcinoid tumors: Anatomy & histopathology | Take Quiz |
Cellular classification & staging of adult primary liver cancer | Take Quiz |
HCC: Prognosis, diagnostic imaging & liver biopsy | Take Quiz |
HCC: Risk factors & diagnosis | Take Quiz |
Pancreatic adenocarcinoma: Staging, radiographic & laboratory evaluation | Take Quiz |
Heritable risk factors for pancreatic adenocarcinoma | Take Quiz |
Pancreatic adenocarcinoma: Imaging studies | Take Quiz |
Pancreatic adenocarcinoma: Features, diagnosis, & management | Take Quiz |
Neuroendocrine tumors: Diagnosis | Take Quiz |
Pancreatic neuroendocrine tumors: Pathogenesis & prognostic factors | Take Quiz |
Colorectal cancer & endoscopic resection | Take Quiz |
USPSTF Guidelines: Update on CRC screening | Take Quiz |
Pathophysiology & prognosis of PDA | Take Quiz |
Staging, radiographic, & laboratory evaluation of PDA | Take Quiz |
Bowel preparation before colonoscopy | Take Quiz |
Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
Colonoscopy surveillance after screening & polypectomy | Take Quiz |
Endoscopy in the staging & management of CRC | Take Quiz |
Gynecologic Cancer
Gynecologic Cancer
Quiz | |
---|---|
Uterine sarcoma treatment | Take Quiz |
Uterine sarcoma types & prognosis | Take Quiz |
Endometrial cancer risk, signs, & symptoms | Take Quiz |
Endometrial cancer: Prognostic factors | Take Quiz |
Ovarian epithelial cancer: Incidence & mortality | Take Quiz |
Ovarian epithelial cancer diagnostic & staging evaluation | Take Quiz |
Ovarian epithelial cancer: Clinical presentation & risk | Take Quiz |
ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
ASCO Guidelines: Cervical cancer screening | Take Quiz |
Subtypes of endometrial cancer | Take Quiz |
Screening & serum biomarkers for EOC | Take Quiz |
Prevention of EOC with RRSO | Take Quiz |
Diagnosis, evaluation, and treatment of EOC | Take Quiz |
Diagnosis & screening of endometrial cancer | Take Quiz |
Risk factors & screening for endometrial cancer | Take Quiz |
Prevention & screening of ovarian cancer | Take Quiz |
EOC pathology | Take Quiz |
Nodal spread & endometrial cancer | Take Quiz |
Rare Diseases
Rare Diseases
Quiz | |
---|---|
Treatment approaches for pancreatic cancer | Take Quiz |
Pancreatic cancer prognosis & overall survival | Take Quiz |
Oncology
Oncology
Quiz | |
---|---|
Active specific immunotherapy | Take Quiz |
CDC Report: Cancer & obesity | Take Quiz |
ASCO Guideline: Systemic therapy for stage IV NSCLC | Take Quiz |
ACOS Guidelines: Biomarkers & early-stage invasive breast cancer | Take Quiz |
ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
NSCLC: Delayed chemo & survival after surgery | Take Quiz |
Breast cancer imaging techniques | Take Quiz |
ASCO Guidelines: Cancer treatment & cardiac dysfunction risk | Take Quiz |
PD-based cancer immunotherapy | Take Quiz |
Lung cancer: The role of imaging studies & chest CT | Take Quiz |
2017 ASCO Quality Symposium highlights | Take Quiz |
USPSTF Guidelines: Update on CRC screening | Take Quiz |
ASCO Guidelines: Management of renal cell masses | Take Quiz |
ASCO Guidelines: Integrating palliative care | Take Quiz |
ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
ASCO Guidelines: Cervical cancer screening | Take Quiz |
AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
Common RCC subtypes | Take Quiz |
AUA-SUO Guidelines: Diagnosis of non-muscle invasive bladder cancer | Take Quiz |
ASCO Guidelines: Adjuvant therapy selection & early-stage breast cancer | Take Quiz |
AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 1 | Take Quiz |
ASCO Guidelines: HER2 testing in BC | Take Quiz |
ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
Bowel preparation before colonoscopy | Take Quiz |
Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
Colonoscopy surveillance after screening & polypectomy | Take Quiz |
Endoscopy in the staging & management of CRC | Take Quiz |
Risk factors & prostate cancer | Take Quiz |
ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
Pediatrics
Pediatrics
Quiz | |
---|---|
Wilms tumor signs, symptoms, & diagnosis | Take Quiz |
Sarcoma & GIST
Sarcoma & GIST
Quiz | |
---|---|
Sarcoma: Laboratory & imaging studies | Take Quiz |
Sarcoma clinical features & risk | Take Quiz |
Sarcoma & GIST pathophysiology | Take Quiz |
Therapies for sarcoma & GIST | Take Quiz |
Sarcoma: Importance of histology | Take Quiz |
Sarcoma imaging: STS or benign processes? | Take Quiz |
High-risk sarcomas & chemoradiation | Take Quiz |
Sarcoma: Radiotherapy benefits | Take Quiz |
Sarcoma: Radiation and surgical options | Take Quiz |
Stages of sarcoma | Take Quiz |
Diagnosing sarcoma | Take Quiz |
Sarcoma: Disease overview | Take Quiz |
Metastatic Breast Cancer
Metastatic Breast Cancer
Quiz | |
---|---|
Managing HER2-positive breast cancer | Take Quiz |
Management of metastatic breast cancer | Take Quiz |
Metastatic breast cancer: Prognosis | Take Quiz |
Management of metastatic breast cancer in pre- and post-menopausal patients | Take Quiz |
Metastatic breast cancer: Reducing complications | Take Quiz |
Metastatic breast cancer: Laboratory & radiology evaluation | Take Quiz |
Metastatic breast cancer & endocrine therapy | Take Quiz |
Metastatic breast cancer: Chemotherapy | Take Quiz |
Treatment of HR positive and HER2 negative tumors | Take Quiz |
Metastatic breast cancer: Pathology & molecular markers | Take Quiz |
Features of metastatic breast cancer | Take Quiz |
De novo metastatic breast cancer: Occurrence & outcome by subtype | Take Quiz |
Metastatic breast cancer: Adapting to changes during treatment | Take Quiz |
Metastatic breast cancer with ESR1 mutation: Clinical management considerations | Take Quiz |
ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
Neuro-oncology
Neuro-oncology
Quiz | |
---|---|
Therapy for glioblastoma | Take Quiz |
Glioblastoma & radiation therapy | Take Quiz |
CNS malignancies: Management of complications | Take Quiz |
Diffuse glioma: Risk factors | Take Quiz |
Breast Cancer
Breast Cancer
Quiz | |
---|---|
Breast cancer diagnosis & management | Take Quiz |
ASCO Guideline: SLN biopsy & early-stage breast cancer | Take Quiz |
ASCO/ASTRO/SSO Guideline: Postmastectomy radiotherapy | Take Quiz |
Management of metastatic breast cancer | Take Quiz |
Breast cancer classification & management | Take Quiz |
Breast cancer risk factors | Take Quiz |
Metastatic breast cancer: Laboratory & radiology evaluation | Take Quiz |
Metastatic breast cancer & endocrine therapy | Take Quiz |
ACOS Guidelines: Biomarkers & early-stage invasive breast cancer | Take Quiz |
Metastatic breast cancer: Chemotherapy | Take Quiz |
Treatment of HR positive and HER2 negative tumors | Take Quiz |
Metastatic breast cancer: Pathology & molecular markers | Take Quiz |
Features of metastatic breast cancer | Take Quiz |
Stage 0 breast cancer: Risk factors & management | Take Quiz |
Stage 0 breast cancer: DCIS & LCIS | Take Quiz |
Breast cancer imaging techniques | Take Quiz |
Breast cancer: Types of surgery | Take Quiz |
Circulating tumor cell clusters & metastatic breast cancer outcomes | Take Quiz |
Breast cancer with leptomeningeal metastasis: Characteristics & outcomes | Take Quiz |
De novo metastatic breast cancer: Occurrence & outcome by subtype | Take Quiz |
Metastatic breast cancer: Adapting to changes during treatment | Take Quiz |
ASCO Guidelines: Adjuvant therapy selection & early-stage breast cancer | Take Quiz |
HER2 overexpression | Take Quiz |
Breast cancer: Tissue diagnosis & imaging studies | Take Quiz |
Early & advanced breast cancer: Use of imaging in evaluation & follow-up | Take Quiz |
Breast cancer: Circulating tumor cells | Take Quiz |
Metastatic breast cancer with ESR1 mutation: Clinical management considerations | Take Quiz |
ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 1 | Take Quiz |
ASCO Guidelines: HER2 testing in BC | Take Quiz |
ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
ASCO/CAP Guidelines: HER2 & FISH testing | Take Quiz |
Factors related to breast cancer surgery choices | Take Quiz |
Obesity & postmenopausal breast cancer risk | Take Quiz |
Breast conservation & neoadjuvant therapy | Take Quiz |
Oophorectomy & breast cancer | Take Quiz |
Leukemia, Myelodysplasia, Transplantation
Leukemia, Myelodysplasia, Transplantation
Quiz | |
---|---|
GVHD after donor lymphocyte infusion | Take Quiz |
Donor lymphocyte infusion: Indications | Take Quiz |
Testing & mutational analysis in chronic myeloid leukemia | Take Quiz |
Melanoma
Melanoma
Quiz | |
---|---|
Melanoma management | Take Quiz |
Melanoma: Pattern recognition & prevalence | Take Quiz |
Conditions that mimic melanoma | Take Quiz |
Diagnosing melanoma | Take Quiz |
Etiology & clinical presentation of BCC | Take Quiz |
Etiology & presentation of squamous cell carcinoma | Take Quiz |
Uveal choroidal melanoma | Take Quiz |
Management of metastatic melanoma | Take Quiz |
Adjuvant treatment of melanoma | Take Quiz |
Melanoma early diagnosis & staging | Take Quiz |
Melanoma risk factors | Take Quiz |
Melanoma: Epidemiology & etiology | Take Quiz |
Clinical features of melanoma | Take Quiz |
Clinical Guidelines
Clinical Guidelines
Quiz | |
---|---|
CDC Report: Cancer & obesity | Take Quiz |
ASCO Guideline: Systemic therapy for stage IV NSCLC | Take Quiz |
ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
ASCO Guidelines: Cancer treatment & cardiac dysfunction risk | Take Quiz |
2017 ASCO Quality Symposium highlights | Take Quiz |
ASCO Guidelines: Management of renal cell masses | Take Quiz |
ATA Guidelines: Intraoperative voice and parathyroid management & follow-up in patients with DTC | Take Quiz |
ATA Guidelines: Voice and parathyroid issues in DTC | Take Quiz |
ASCO Guidelines: Integrating palliative care | Take Quiz |
ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
ASCO Guidelines: Cervical cancer screening | Take Quiz |
AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
Common RCC subtypes | Take Quiz |
AUA-SUO Guidelines: Diagnosis of non-muscle invasive bladder cancer | Take Quiz |
ASCO Guidelines: Adjuvant therapy selection & early-stage breast cancer | Take Quiz |
AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 1 | Take Quiz |
ASCO Guidelines: HER2 testing in BC | Take Quiz |
ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
Bowel preparation before colonoscopy | Take Quiz |
Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
Colonoscopy surveillance after screening & polypectomy | Take Quiz |
Endoscopy in the staging & management of CRC | Take Quiz |
Risk factors & prostate cancer | Take Quiz |
ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
Preventive Care
Preventive Care
Quiz | |
---|---|
CDC Report: Cancer & obesity | Take Quiz |
Lung Cancer
Lung Cancer
Quiz | |
---|---|
ASCO Guideline: Systemic therapy for stage IV NSCLC | Take Quiz |
Non-small cell lung cancer: Thoracic symptoms, metastatic disease, & paraneoplastic syndrome | Take Quiz |
Non-small cell lung cancer: Subtypes & management | Take Quiz |
Lung cancer: Risk factors, diagnosis, & screening | Take Quiz |
NSCLC: Delayed chemo & survival after surgery | Take Quiz |
EGFR tyrosine kinase inhibition & lung cancer | Take Quiz |
Lung cancer: Molecular profiling | Take Quiz |
Lung cancer: The role of imaging studies & chest CT | Take Quiz |
Understanding lung cancer | Take Quiz |
Advanced & previously treated NSCLC: The OAK & POPLAR trials by Bobby Daly, MD, MBA | Take Quiz |
PD-L1-Positive NSCLC and KEYNOTE-024, by Bobby Daly, MD, MBA | Take Quiz |
Pathology & clinical presentation of small cell lung cancer | Take Quiz |
Staging & imaging of small cell lung cancer | Take Quiz |
Treatment of stage IIIA NSCLCs | Take Quiz |
RAS mutations in NSCLC by Kevin Wood, MD | Take Quiz |
Treatment of early-stage NSCLCs | Take Quiz |
Clinical evaluation of single pulmonary nodules | Take Quiz |
NSCLC risk and subtypes | Take Quiz |
Lung cancer pathology | Take Quiz |
GI Oncology
GI Oncology
Quiz | |
---|---|
HCC: Risk factors & diagnosis | Take Quiz |
Pancreatic adenocarcinoma: Staging, radiographic & laboratory evaluation | Take Quiz |
Heritable risk factors for pancreatic adenocarcinoma | Take Quiz |
Pancreatic adenocarcinoma: Imaging studies | Take Quiz |
Pancreatic neuroendocrine tumors: Pathogenesis & prognostic factors | Take Quiz |
Colorectal cancer & endoscopic resection | Take Quiz |
USPSTF Guidelines: Update on CRC screening | Take Quiz |
Risk factors & screening for gastric cancers | Take Quiz |
Risk factors associated with PDA | Take Quiz |
Diagnostic laparoscopy & management of PDA | Take Quiz |
Management of PDA & metastatic disease | Take Quiz |
Treatment of esophageal cancer | Take Quiz |
Pathology & staging workup of esophageal cancer | Take Quiz |
Diagnosing PDA: Imaging & aspiration/biopsy | Take Quiz |
Clinical presentation & diagnosis of esophageal cancer | Take Quiz |
Epidemiology & etiology of esophageal cancer | Take Quiz |
Gastric cancer prevention | Take Quiz |
Rectal cancer: Neoadjuvant therapy vs surgery | Take Quiz |
Adenoma detection rates in CRC | Take Quiz |
Preoperative chemotherapy & colorectal cancer | Take Quiz |
Familial adenomatous polyposis & CRC | Take Quiz |
Screening of CRC | Take Quiz |
Colonoscopy: Optimizing adequate bowel cleansing | Take Quiz |
ASCO Guidelines: Surveillance protocol for survivors of CRC | Take Quiz |
Epidemiology & risk factors of CRC | Take Quiz |
Genetic evaluation & management of Lynch syndrome | Take Quiz |
Laparoscopic resection vs surgery for rectal cancer | Take Quiz |
Risk factors & prognosis of rectal cancer | Take Quiz |
Understanding hereditary CRC syndromes: Part 2 | Take Quiz |
Colorectal cancer screening: Flexible sigmoidoscopy | Take Quiz |
Nonmelanoma Skin Cancer
Nonmelanoma Skin Cancer
Quiz | |
---|---|
Non-melanoma skin cancer: Basal cell carcinoma & squamous cell carcinoma | Take Quiz |
First FDA-approved Merkel cell carcinoma treatment | Take Quiz |
Renal Cell Carcinoma
Renal Cell Carcinoma
Quiz | |
---|---|
ASCO Guidelines: Management of renal cell masses | Take Quiz |
RCC subtypes: Risk factors, clinical findings, & imaging | Take Quiz |
Common RCC subtypes | Take Quiz |
AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
Staging & surveillance of RCC | Take Quiz |
Minimally invasive surgery for RCC | Take Quiz |
Pathophysiology & prognosis of RCC | Take Quiz |
Unique patient categories in RCC | Take Quiz |
Management of localized RCC | Take Quiz |
Case-Based Quizzes
Case-Based Quizzes
Quiz | |
---|---|
Advanced & previously treated NSCLC: The OAK & POPLAR trials by Bobby Daly, MD, MBA | Take Quiz |
PD-L1-Positive NSCLC and KEYNOTE-024, by Bobby Daly, MD, MBA | Take Quiz |
Quiz | |
---|---|
Screening & prevention of head & neck cancer | Take Quiz |
Prognosis of head & neck cancer | Take Quiz |
Epidemiology & risk factors associated with head & neck cancer | Take Quiz |
Diagnosis & staging of head & neck cancer | Take Quiz |
Diagnosis & management of infectious disease syndromes | Take Quiz |
Evaluation of a neutropenic patient with fever | Take Quiz |
Myelodysplastic syndrome | Take Quiz |
Therapeutic approaches to myelodysplastic syndrome | Take Quiz |
Mixed Topics
Mixed Topics
Quiz | |
---|---|
Empirical antifungal therapy of fever & neutropenia | Take Quiz |
Syndromes of fever during neutropenia | Take Quiz |
Quality Care in Oncology by Bobby Daly, MD, MBA | Take Quiz |
Empirical antibiotic therapy of fever & neutropenia | Take Quiz |
Fertility preservation among cancer patients | Take Quiz |